FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

HTO Nevada New & Improved Blue Gel Anesthetic Recall

New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive p…

HTO Nevada, Inc. · Lake Oswego, OR

Risk level
Class II
Reported by FDA
Feb 22, 2023
Recall ID
D-0270-2023
Check your lot numberHow we source this data

Summary

HTO Nevada recalled New & Improved Blue Gel Anesthetic starting Feb 9, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0270-2023 on Feb 22, 2023. Reason: cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API. Status: Terminated.

Why it was recalled

cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

Product description

New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%).

Lot numbers, UPCs & expiration codes

Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024.

Where it was sold

Nationwide in the USA and Canada.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0270-2023
Classification
Class II
Status
Terminated
Recall initiated
Feb 9, 2023
FDA report date
Feb 22, 2023
Quantity
4709 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
HTO Nevada, Inc.

Original FDA data

Every field from FDA enforcement report D-0270-2023, exactly as published.

Show all FDA fields
City
Lake Oswego
State
OR
Status
Terminated
Country
United States
Event ID
91694
Address
6400 Rosewood St
Code information
Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024.
Postal code
97035-5392
Report date
Feb 22, 2023
Product type
Drugs
Recall number
D-0270-2023
Classification
Class II
Recalling firm
HTO Nevada, Inc.
Product quantity
4709 bottles
Termination date
Nov 17, 2023
Reason for recall
cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Voluntary / mandated
Voluntary: Firm initiated
Product description
New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%).
Distribution pattern
Nationwide in the USA and Canada.
Recall initiation date
Feb 9, 2023
Initial firm notification
Letter
Center classification date
Feb 15, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0270-2023, published Feb 22, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls